Orisun Acquisition Corp.

The extension is funded half by a sponsor-side entity and half by Ucommune, the target Orisun agreed to buy on June 29, 2020 — so the counterparty to the merger is paying to keep the SPAC's clock running, the same structure JFK used with Diginex. The money goes into the trust rather than to the company. The report states no new completion date and no per-share deposit rate, so the length of the extension purchased is not established here.

This is the deal announcement, and the control structure is the term to notice: Class B shares carry fifteen votes each against one for Class A, so 9,452,407 Class B shares hold roughly 141 million votes before any Class A is counted. All seven post-closing directors are designated by Ucommune. The earn-out adds up to 4,000,000 Class A shares on either price or revenue tests — $16.50 or RMB850 million of 2020 revenue, $22.75 or RMB1,275 million for 2021, $30.00 or RMB1,912 million for 2022.

The August 6, 2020 date is not fixed: the company may extend up to three times by three months each, to 21 months in total, but only if the Sponsor or a designee deposits $444,002 ($0.10 per public share) each time - so the going-concern date and the outer date are two different things, and the second depends on someone electing to pay. Trust figures are March 31, 2020 balances, not redemption prices. Detect-only: nothing was written to a deadline, trust, floor or status field.

The deadline in this document is an extendable one and must not be read as a single date: the company had until August 6, 2020, extendable up to three times by three months each - 21 months total - and each extension requires the Sponsor or its designee to deposit $444,002 ($0.10 per public share) into trust. So the outer date is contingent on someone electing to pay, three times. The $44,694,457 is a December 31, 2019 balance, not a redemption price. Nothing was written to a deadline, trust or status field.

The incoming CFO takes a board seat at the same time, and the filing describes him as an investment professional at a family office it identifies with the surname of the company's chief executive, Wei Chen — a relationship the disclosure states without elaborating. The filing gives no reason for the outgoing CFO's resignation and discloses no disagreement.

The $1,332,010 deferred underwriting fee matches the as-adjusted figure in the pro forma balance sheet the company furnished in September, confirming the over-allotment was taken up as shown there. Redemption value is approximately $10.03 per share ($38,613,098 over 3,850,841), just above the $10.00 the trust was funded at. The sponsor note is repaid and the company held $380,111 of cash outside the trust, so it was self-funding at the period end. This quarter includes the period of the Nasdaq round-lot-holder deficiency but the captured text does not address it.

The delisting risk disclosed in August is resolved in the company's favour, so the units keep their listing. The August filing had said the company did not expect to separate the units until it received the Panel's decision; that decision has now been received, though this report does not state whether or when separation will occur, and it does not state any conditions the Panel attached to continued listing.

This is the pre-trust balance sheet: no trust account appears in the June 30 figures, and the company was funding formation and offering costs from $41,985 of cash plus a $225,000 sponsor note. The gap between 1,150,000 shares at June 30 and 5,370,000 on the September 9 cover is the IPO closing between the period end and the filing date, so none of the financial statements in this report reflect trust assets or public shares.

Redemption value is carried at exactly $10.00 per public share in both columns ($34,290,530 over 3,429,053 shares and $38,558,760 over 3,855,876), and permanent stockholders' equity is unchanged at $5,000,009, so the additional $4,400,240 is absorbed entirely by the trust and the redeemable-share classification rather than by equity. One printed figure does not foot: the as-reported total assets line reads $450,724,539 against components summing to $40,724,539, which is the number the rest of that column is consistent with; the as-adjusted total of $45,124,779 does foot.

Unit separation, which the IPO structure contemplates, is deferred with no stated date: holders cannot trade the share, right and warrant components separately while the deficiency stands, and the continued listing of the units themselves depends on a hearing request the filing describes only as intended. The test failed here is a holder-distribution test rather than a financial one, and the filing states no Panel deadline and no cure period.

Establishes a $10.00 trust of $40 million with $1,200,000 of deferred underwriting against it — 3% of the offering — and $652,039 of working capital for a search on a 12-month base clock.

Sets an unusually short base deadline of 12 months from closing, extendable in three-month increments to 21 months, and locks the insiders' votes in favour of whatever combination is put forward.

The clock is 12 months, not the 18 or 24 this tier usually carries, and it extends to a maximum of 21 months in three separate three-month steps. Each step requires the insiders to deposit $400,000 - $0.10 per share - into the trust five days before the applicable deadline, in exchange for a non-interest-bearing promissory note. No shareholder vote and no redemption right attaches to any of the three. The warrant call trigger is $16.50, not $18.00, for 20 of 30 trading days, and it may be exercised at any time while the warrants are exercisable.

What changed: VOTE RESULTS, filed as additional proxy material: Orisun held its special meeting on 16 Nov 2020 and approved the Ucommune transaction. Of 5,783,235 shares entitled to vote at the 7 Oct 2020 record date, 4,376,688 (75.68%) were voted; the Reincorporation Merger and the Acquisition Merger each passed 4,326,688 for to 50,000 against, and the 2020 Equity Incentive Plan passed on the same numbers. The filing also discloses Backstop Agreements under which PubCo will register the resale of PIPE Shares, and the sponsor's rename from Everstone Investments LLC to EverGlory Investments LLC. Why it matters: This is the moment the redemption window for the deal closes and the outcome becomes fact rather than proposal: holders who did not act are now in the combined company. Under the structure Orisun reincorporates by merging into PubCo (Cayman) while Everstone International Ltd merges into Ucommune, leaving Ucommune a wholly-owned subsidiary — so the surviving listed issuer is PubCo, not Orisun. The Backstop Agreements are the redemption shock-absorber: PIPE Shares issued under Section 4(a)(2), Regulation D and Regulation S, with resale registration promised after closing.

What changed: Third quarter 2020 10-Q for a 2019-vintage shell. Marketable securities held in trust were $45,229,740 at September 30, 2020, against $44,694,457 at December 31, 2019, lifted by sponsor extension deposits of $444,002 per three-month extension. Cash outside trust collapsed to $55,037 from $336,270 and the working capital deficit was $181,099. Convertible promissory notes of $422,001 plus $222,001 from a related party were outstanding, with $305,401 accrued expenses and $1,332,010 deferred underwriting. Redeemable shares fell to 3,736,581 from 3,831,138, carried at $38,017,486. Why it matters: Substantial doubt about going concern is disclosed and tied explicitly to February 6, 2021, the final extended date by which the company must cease operations if no business combination closes. With $55,037 of cash the shell is entirely dependent on insider and third-party lending: it drew a $200,000 note from an unrelated third party on August 17, 2020 convertible into IPO-identical units at $10.00, which dilutes public holders if a deal closes. About $385,000 of trust was interest available for taxes, and $75,756 of interest had already been withdrawn through September 30, 2020.

What changed: Orisun Acquisition Corp. issued definitive merger materials, dated November 5, 2020 and first mailed the same day, for a special meeting at 10:00 a.m. Eastern time on November 16, 2020 held by teleconference. Under the merger agreement dated June 29, 2020 the combination runs in two steps: Orisun reincorporates by merging into Ucommune International Ltd, a Cayman company that becomes PubCo, and concurrently Everstone International Ltd merges into Ucommune Group Holdings Limited. Consideration is $700,000,000, paid as 70,000,000 PubCo ordinary shares valued at $10.00 each. Why it matters: Voting control moves with the share class rather than the count: PubCo Class B ordinary shares carry fifteen votes each against one for Class A, and Ucommune's former shareholders receive 53,358,932 Class A and 9,452,407 Class B shares, of which 3,140,567 sit in escrow against indemnification claims. A further 7,188,661 Class A shares are reserved for the 2020 incentive plan. The earn-outs are dual-triggered — 2,000,000 shares on a $16.50 VWAP before December 31, 2022 or FY2020 revenue above RMB850,000,000, then 1,000,000 more on a $22.75 VWAP before December 31, 2023.